Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 day ago Contract award

Poland - Pharmaceutical products - Purchase of pharmaceutical products - chemotherapy

Original Polska - Produkty farmaceutyczne - Zakup produktów farmaceutycznych - chemioterapia

Awarded Poland Warszawski stołeczny Medical equipment & pharmaceuticals

Buyer Szpital Grochowski im. dr med. Rafała Masztaka spółka z ograniczoną odpowiedzialnością

€234,795 awarded value

Key facts

Awarded
Estimated value
€430,296
converted from PLN
Procedure
Open procedure
  1. Awarded
  2. Published
  3. Contract ends, estimated July 2028
View the official notice Watch this tender

This contract runs about 24 months, so it is back on the market around July 2028. Log in

Awarded to

Farmacol-Logistyka Sp. z o.o.; LEK S.A.; Urtica Sp. z o.o.; Asclepios S.A.; Optifarma Sp. z o. o. Sp. K.; Tramco Sp. z o.o.

Awarded value
€234,795 45% under the estimate of €430,296
Award date
Bids received
18 over 8 lots
Record with this buyer
1 first contract from this buyer in the register
Back on the market
Jul 2028 How we know

When this contract comes back

estimated from the stated duration

This contract runs about 24 months, so it is back on the market around July 2028.

Every contract expiring, on the radar

Summary

Machine-generated summary

Szpital Grochowski im. dr med. Rafała Masztaka spółka z ograniczoną odpowiedzialnością purchased chemotherapy medicines in successive deliveries. The contract covered eight lots: Cabazitaxelum, Cyclophosphamidum, Fluorouracilum, Sacituzumabum govitecanum, Bicalutamidum, Capecitabinum, Abemaciclibum and Acidum zoledronicum. Partial deliveries were due within 3 working days of ordering. The contract was awarded on 2026-07-29 to Farmacol-Logistyka Sp. z o.o., LEK S.A., Urtica Sp. z o.o., Asclepios S.A., Optifarma Sp. z o. o. Sp. K. and Tramco Sp. z o.o. for about EUR 234,795.12 (converted from PLN at the ECB reference rate), 45% below the estimate of PLN 1,848,337.96 (about EUR 430,296.35, converted from PLN). The contract runs for 24 months and is expected to end and come back to market on 2028-07-28.

Description

Przedmiotem zamówienia są dostawy sukcesywne produktów farmaceutycznych - chemioterapia. Opis przedmiotu zamówienia znajduje się w załączniku nr 2 do SWZ (formularz asortymentowo-cenowy). Wymagany termin realizacji dostaw częściowych: 3 dni robocze od złożenia zamówienia. Minimalny termin ważności asortymentu: 12 miesięcy od daty dostawy. Zamawiający zobowiązany będzie do wykorzystania minimum 75% wartości brutto udzielonego zamówienia. Wykorzystanie zależne będzie od liczby pacjentów zgłaszających się do Zamawiającego oraz od umów (kontraktów) z Narodowym Funduszem Zdrowia. Zamawiający dopuszcza możliwość składania ofert częściowych (8 - zadań / części zamówienia), zgodnie z podziałem określonym w załączniku nr 2 do SWZ stanowiącym Opis przedmiotu zamówienia: 1) zadanie nr 1 - Cabazitaxelum; 2) zadanie nr 2 - Cyclophosphamidum; 3) zadanie nr 3 - Fluorouracilum; 4) zadanie nr 4 - Sacituzumabum; 5) zadanie nr 5 - Bicalutamidum; 6) zadanie nr 6 - Capecitabinum; 7) zadanie nr 7 - Abemaciclibum; 8) zadanie nr 8 - Acidum zoledronicum. Cabazitaxelum, koncentrat do sporządzania roztworu do infuzji, 10 mg/ml; Cyclophosphamidum, koncentrat do sporządzania roztworu do wstrzykiwań / do infuzji, 100 mg/ml; Fluorouracilum, roztwór do wstrzykiwań i infuzji, 500 mg sporządzania roztworu do infuzji, 5 mg/ml; Sacituzumabum govitecanum, proszek do sporządzania koncentratu roztworu do infuzji, 200 mg; Bicalutamidum, tabl. powl.; Capecitabinum, tabl. powl., 150 mg, 500 mg; Abemaciclibum, tabl. powl., 50 mg, 100 mg, 150 mg; Acidum zoledronicum

8 lots

Lot 1
Cabazitaxelum estimated €127,095 · 24 months
Lot 2
Cyclophosphamidum estimated €416 · 24 months
Lot 3
Fluorouracilum estimated €1,809 · 24 months
Lot 4
Sacituzumabum govitecanum estimated €203,940 · 24 months
Lot 5
Bicalutamidum estimated €10,318 · 24 months
Lot 6
Capecitabinum estimated €1,218 · 24 months
Lot 7
Abemaciclibum estimated €67,969 · 24 months
Lot 8
Acidum zoledronicum estimated €8,436 · 24 months
How tenders are scored
Cena: 100 points

As the official notice states them.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 day ago

What this buyer has paid before

Based on 59 comparable contracts this buyer awarded in this sector over the last 4 years.

This award
€234,795
Estimated value
€430,296
Median award
€140,173
Middle half of past awards
€54,690 to €295,904

The award sits inside the usual range.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Szpital Grochowski im. dr med. Rafała Masztaka spółka z ograniczoną odpowiedzialnością

Poland

notices in the register
216
awards
100
awarded in total
€19.0M

Who wins its contracts

Many suppliers
different companies won its awards
69
of the awards went to the three most frequent winners
18%
of its calls state an estimated value
80%

Based on 88 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.5
of those lots received a single tender
68%
of the awards went to companies based in another country
1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Awards most often to

  1. Jol-Mark Sp. z o.o. 9 awards €379,587
  2. URTICA Sp. z o.o. 5 awards €825,306
  3. Medtronic Poland Sp. z o.o. 2 awards €1.6M

1 open tender right now

Market context

open now in Medical equipment & pharmaceuticals
8,281
median open notice
€306,699

Who wins in this market

Many suppliers

Poland · Medical equipment & pharmaceuticals

different companies won awards here
13,424
of the awards went to the three most frequent winners
4%
buyers awarded contracts here
1,462

Based on 23,003 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.8
of those lots received a single tender
63%
of the awards went to companies based in another country
2%
of the tenders came from another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

Awarded before

Never miss a tender like this

993 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language